- AIRC Associazione Italiana per la Ricerca sul Cancro
CALL FOR PROPOSALS 2013
Fellowships for Italy
Current address:
Via San Vito 7, 20123 Milano
tel. 02/7797222-374
fax 02/7797259
email: [email protected]
Technical support: tel. 02/7797224
Legal address: Via Corridoni 7, 20122 Milano
[AIRC – fellowships Italy call 2013]
In this Call:
5 triennial fellowships
9 biennial fellowships
5 annual fellowships
Fellowships
Donors’ requirements
2 triennial fellowships
“Borromeo”
2 triennial fellowships
“Clienti Carrefour”
1 triennial fellowship
“Antonietta Latronico”
1 biennial fellowship
“Ferdinando Burigana e Renata Coi”
1 biennial fellowship
“Gemma Del Cornò”
top priority will be given to applicants intending to move
to a different city or region to carry out their research
top priority will be given to applicants intending to move
to a different city or region to carry out their research
top priority will be given to applicants intending to move
to a different city or region to carry out their research
top priority will be given to applications with a research
plan focused on bone cancer
top priority will be given to applications with a research
plan focused on breast or lung cancer and to be carried
out in Lazio
top priority will be given to applications with a research
plan focused on pancreas or biliary duct cancer
top priority will be given to applications with a research
plan to be carried out in Veneto
top priority will be given to applicants intending to move
to a different city or region to carry out their research
top priority will be given to applicants intending to move
to Veneto or from Veneto to carry out their research
top priority will be given to applications with a research
plan to be carried out in Veneto
top priority will be given to applicants intending to move
to a different city or region to carry out their research
top priority will be given to applications with a research
plan focused on colon or liver cancer and to applicants
intending to move to Puglia or from Puglia to carry out
their research
top priority will be given to applications with a research
plan to be carried out in Veneto
top priority will be given to applications with a research
plan to be carried out in Veneto
top priority will be given to applications with a research
plan focused on female cancers and to be carried out in
Veneto
top priority will be given to applications with a research
plan to be carried out in Veneto
top priority will be given to applications with a research
plan focused on colon cancer and to applicants intending
to carry out their research in Puglia
1 biennial fellowship
“Antonino Ippolito e Luigi Nappa”
1 biennial fellowship
“Ermanno Pasquetto e Francesco Scanferla”
1 biennial fellowship
“Giovanna Ciani”
1 biennial fellowship
“Starwood Hotel Europa & Regina Venezia”
1 biennal fellowship
“Volontari del Comitato veneto e Trentino Alto Adige”
1 biennial fellowship
“Starwood Hotels and Resorts”
1 biennial fellowship
“Salvatore Maisto e Franco Marzano”
1 annual fellowship
“Albergatori e Volontari, Città di Jesolo”
1 annual fellowship
“Volontari gruppo pro Lughetto (VE)”
1 annual fellowship
“Hard Rock Cafe Venice”
1 annual fellowship
“Centro Studi Ricerche Ligabue”
1 annual fellowship
“Enzo Manduzio”
2
[AIRC – fellowships Italy call 2013]
TABLE OF CONTENTS
Foreword .............................................................................................................................................. 4
Eligibility criteria for applicants .......................................................................................................... 4
The hosting institution ......................................................................................................................... 4
The research plan ................................................................................................................................. 5
The review process............................................................................................................................... 5
Funding ................................................................................................................................................ 5
Duration and Renewals ........................................................................................................................ 6
Bio-Ethical Requirements .................................................................................................................... 6
Guide to proposal preparation .............................................................................................................. 6
Type of fellowship .......................................................................................................................................................... 7
Your personal data .......................................................................................................................................................... 7
Administrative Data ........................................................................................................................................................ 7
Curriculum vitae ............................................................................................................................................................. 7
Certificate of graduation ................................................................................................................................................. 8
Publications .................................................................................................................................................................... 8
Project keywords ............................................................................................................................................................ 9
Research project ............................................................................................................................................................. 9
Head of the hosting lab ................................................................................................................................................... 9
Letter of acceptance by the head of the hosting lab ...................................................................................................... 10
Research and professional experience of the head of the hosting lab ........................................................................... 10
Publications of the head of the hosting lab ................................................................................................................... 10
Head of the laboratory of origin.................................................................................................................................... 10
Letter of presentation by the head of the laboratory of origin (only in case of mobility) .............................................. 10
Bio-Ethical Requirements ............................................................................................................................................. 10
Submission .................................................................................................................................................................... 11
Deadlines ............................................................................................................................................ 12
Keywords………………………..………………………………………………………after page 13
3
[AIRC – fellowships Italy call 2013]
Foreword
The Associazione Italiana per la Ricerca sul Cancro (AIRC) will award a total of 19 Fellowships in
cancer research to highly qualified young graduates and/or post-doctoral fellows or equivalent who
wish to broaden or acquire new experience in oncological research in a cancer-focused laboratory.
Eligibility criteria for applicants
At the deadline for application submission, for any type of fellowship the following eligibility
criteria must be met:
• applicants must have a degree in Medicine, Biological Sciences, Pharmacy, Chemistry and
Pharmaceutical Technology, Medical Statistics, Medical Biotechnologies or other scientific
disciplines, provided that the focus of the proposed research plan in the application is
cancer;
• the degree should be an Italian laurea magistralis, i.e. 5-6 years of undergraduate degree, or
an equivalent non Italian degree (candidates who only have a “laurea breve” are not
eligible), and it should have been attained after December 31, 2006. Exceptions are allowed
only in case of research interruptions due to parental leave, children care, illness.
Applications from researchers who do not meet these requirements will be rejected.
Furthermore:
• the choice to carry out the research activity in an Institute located in a different place from
the one of origin will be a determining factor when awarding mobility fellowships (for
example, fellowships “Borromeo”), and in general it will be considered a preferential title
for all fellowships;
• fellowships are not compatible with any other continuous employment income;
• several fellowships have specific requirements, asked by the donors and listed on page 2 of
this Call. Unless stated otherwise (i.e. “applicants must …”), please note that several of
these requirements are not mandatory but only represent a priority criterion. Through the
online application form candidates automatically apply to all AIRC fellowships available in
this Call. We urge all applicants to apply both to AIRC and FIRC Fellowships for Italy.
Applicants can indicate the duration of the fellowship they prefer (1-2-3 years) through the
application form. At the end of the review process the staff of the AIRC Peer Review Office
will determine which applicants in the fundability range of the final ranking have the
characteristics required for each fellowship (see “The review process”, below);
• applicants who have already been awarded one triennial AIRC or FIRC fellowship for Italy
cannot apply to this Call. Researchers cannot be supported by AIRC/FIRC fellowships for
more than three years total (e.g. recipients of a two-year AIRC or FIRC fellowship would be
eligible ONLY for an annual fellowship);
• a maximum of two candidates per research group (i.e. having the same head of the lab
of origin) may apply.
The hosting institution
The hosting institution must be a non-profit research institution (possible revenues must be
reinvested in research activities) in Italy, with the mission to develop biomedical research and to
disseminate its results.
Successful candidates must operate in the Italian hosting institution for the entire duration of the
fellowship. Any change occurring in the relationship between the fellow and the hosting institution
(e.g. termination, leave of absence) or in the hosting institution legal entity or organization (e.g.
changes in Institution name, merging, Legal representative turn-over, changes in addresses) must be
promptly notified to AIRC.
4
[AIRC – fellowships Italy call 2013]
Hosting institutions must assure optimal working conditions to the fellows: in addition to providing
facilities, equipment, and infrastructure, the hosting institution, and especially the head of the
hosting lab, are expected to offer adequate training resources and cover expenses to travel to
conferences and meetings when they are deemed important for the training and education of the
fellow.
A letter of acceptance of the applicant by the head of the hosting lab must be included in the
application, describing all resources and training opportunities available. The head of the hosting
lab is expected to supervise the work of the fellow, and provide training and mentoring.
The research plan
Applications must include a detailed research plan, agreed with the head of the hosting lab, with a
clear focus on cancer.
The review process
Applications from fellows who meet the eligibility requirements undergo a peer review process that
ensures a fair, independent and expert evaluation of applications. Applications will be evaluated by
three members of AIRC/FIRC Fellowships Scientific Committee (CSB). Reviewer assignments are
made in compliance with conflict of interest and appearance of conflict rules to ensure a review free
from inappropriate influence (e.g. no application from a given research Institution is assigned to
reviewers from the same Institution or the same city). When accepting to evaluate an application,
reviewers agree that they will maintain the confidentiality of the application and associated
materials they have received.
The following review criteria will be used to evaluate applications:
• curriculum vitae and track-record of the applicant;
• quality of the hosting laboratory and of the hosting institution (also in terms of training
potential);
• quality of the research project and its relevance to cancer.
For each application, the scores received from all reviewers will be averaged to generate the
application’s global score, which will be used to rank the applications. The selection will be
exclusively based on this ranking and, subsequently, on the eligibility of each applicant to the
specific requirements of each fellowship (fellowships may have requirements, generally asked by
donors, in terms of duration, topic of research, region of provenance of the applicants, region where
the research has to be carried out; when present, such requirements are indicated on page 2 of the
Call).
At the end of the review process, on the date indicated in the Deadlines table, all proponents will be
notified of the final decision on their application with an official communication from AIRC, and
the anonymous reviewers’ comments will be available online for each applicant. The decision
concerning the approval of an application cannot be appealed.
Funding
The gross annual amount of each fellowship is € 20.000 per year, or € 25.000 per year in case of
mobility fellowships (i.e. the applicant moves to a hosting institution located in a different city or
region than the one of origin). AIRC will transfer the fellowship funds to the hosting institution,
which will then pay the fellow directly. Please note that it will not be possible to grant a
fellowship if an agreement regulating the administrative responsibilities and management of
the fellowship award is not signed between the hosting institution and AIRC.
Please note that fellowships are not tax-exempt: revenues taxes will be deducted.
5
[AIRC – fellowships Italy call 2013]
Duration and Renewals
Fellowships have a duration of either one, two or three years (see page 2). In a specific section of
the application form it will be possible to indicate the preference. Independently of the duration, all
fellowships will start on January 1st 2014. Renewals for biennial and triennial fellowships must be
submitted yearly (see Deadlines), through the appropriate online forms. At the end of the funding
period, a final scientific report is required for all fellowships (see Deadlines).
Bio-Ethical Requirements
Ethics Committee approval is mandatory for studies involving human subjects, human biological
samples or animal models, according to current international and national rules, and must be
submitted with the full application. The fellowship will not be awarded in the absence of an Ethics
Committee clearance. If the approval from the Ethics Committee(s) is not available by the
submission deadline, the applicant must obtain it by November 15th 2013 and either upload it as
PDF file in the “Personal Area” or send it to the AIRC Peer Review Office by e-mail
([email protected]).
Guide to proposal preparation
To apply, click on the “Area Ricercatori” of the site www.airc.it
PLEASE NOTE: AIRC has redesigned its web-based platform for submitting applications.
Please make sure to read the instructions carefully, as there are some major differences with
the previous system.
• For researchers that already have an AIRC account: access the “Personal Area” with the “old”
username but use the password: Airc.2013
You will be asked to change this password on your first login.
In the “Old password” field, please enter: Airc.2013
• First-time applicants must register in our system: please click on “Register” and provide the
requested information, including your tax code (codice fiscale). The registration will be confirmed
by e-mail and a username and password will be provided.
To launch the application form for the first time, click on “Calls”, select “Fellowships”, then click
on “Apply” in the Fellowships for Italy 2013 section. In the next window, click on “Access the
application form”. Subsequently, to access the application in progress, click on “Submissions” and
then click on “Access the application form”.
We urge all applicants to apply to both AIRC and FIRC Fellowships for Italy: in the “Type of
fellowships” section of the online application form, please select “Both” and save.
Before continuing, please read the following general features of our online system:
-
the system automatically launches the “Type of fellowship” form. All forms that must be
filled out are listed on the left side of the page. Click on each one of them and fill in all the
mandatory fields (in bold). Make sure to click on “SAVE” after completing each form;
-
the forms can be filled out at different times and the work can be interrupted/resumed at
will;
-
a number of forms must be submitted as PDF files. Each file cannot exceed 2Mb. Any file
exceeding such a limit will be automatically rejected by the system. Secure PDF files
6
[AIRC – fellowships Italy call 2013]
cannot be uploaded. Documents submitted as PDF files must be written using an A4
format, single spaced, with margins not less than 2 cm and a font not smaller than 12 point
(preferably Palatino, Times, Arial). Do not exceed the page limit indicated for each
section: the system will not allow the upload of a number of pages beyond the limit;
-
the “Summary” section (last title in the list of forms on the left) allows applicants to:
a. check and see whether each form has been correctly filled out. Forms that are
complete are marked with a green “OK” box; forms that are incomplete have a red
“KO” box together with a list of the specific fields that have not been filled out; non
mandatory forms are “OK” by default even if they have not been completed;
b. view and print the application in its incomplete/complete state. By clicking on
“Create draft” and then on “Open submission draft” you can download the PDF draft
generated by the system;
c. submit the application. Once all mandatory forms are complete, please click on
“Submit”. Be aware that after clicking on “Submit” it will not be possible to make
any further modifications;
-
the complete proposal is automatically assembled as a whole PDF file at the end of the
online procedure;
The application must be written entirely in English. Applications that do not conform to all the
requirements in these instructions will be rejected.
Type of fellowship
Please indicate the preferred duration of the fellowship, and the funding body (AIRC, FIRC, both).
We urge applicants to select “Both”.
Your personal data
Please fill in the requested fields, entering:
• the title of the proposal. The title must not exceed 120 characters, small cases, spaces included. It
should be neither too specific (abbreviations of molecules names such as “Role of PGCI in tumor
progression” may not be clear enough), nor too vague (such as “Analysis of tumor
metastatization”);
• the applicant’s personal data (title, birth date, gender, etc.), unless already provided when
registering into the AIRC website; also, please enter the applicant’s home address and contact data.
If possible, please provide a mobile phone number. Please note: the PI is the prospective fellow
and not the head of the hosting lab;
• all information regarding the degree obtained and, if applicable, the PhD.
Administrative Data
Please provide the requested information about the Legal representative (Legale rappresentante) of
the Institution. The Legal representative will be responsible, along with the fellow’s supervisor, of
all the legal and administrative duties of the fellowship award. The “Institution” field is
automatically filled out when this information is entered in the “Your personal data” section.
Curriculum vitae
The Curriculum vitae with a description of the scientific activity carried out must be uploaded as
PDF file (maximum 2 pages, approx. 1000 words). If applicable, please indicate whether there have
been any research interruptions for periods longer than 6 months between 2008 and 2013 due to
parental leave, children care, illness. Include appropriate documentation to certify the career break
(e.g. birth certificate in case of maternity leave). The CV and, for research interruptions, supporting
documents must be uploaded as a single PDF file. Do not include the applicant’s publications in
the CV, as there is a specific section of the online form to upload them.
7
[AIRC – fellowships Italy call 2013]
Certificate of graduation
The Certificate of graduation with the scores obtained in individual examinations must be attached
as PDF file of the scanned original. To facilitate the work of reviewers who may not be familiar
with the academic transcripts of the applicant’s country, please include a page with a description (or
translation) of the certificate provided and of the score range. For example, explain that the scores
of individual exams can range from X to Y, Y being the best score obtainable. Do the same in case
there is a final score for the degree obtained.
Publications
The list of publications of the fellow from the past five years (2008-2013) has to be selected
through the online procedure. To do so, a number of options is available; click on any that applies.
Add from MyPub
This interface lists all publications previously entered into the system (e.g. through prior
applications, or entered directly into the MyPub section of the Personal Area). By selecting
some or all of these publications, they will be uploaded in the current form; please make sure
the flags are correct.
Add PubMed publications
Within this interface the system launches a PubMed search and provides a list of PubMedrecorded publications spanning from 2008 to 2013. Enter the applicant’s first and middle
initials, and click on “Find”. If the applicant has published with a different last name than that
used to register into the AIRC account (e.g. married vs maiden name), check the “Change
surname” box, and then click on “Find”. Alternatively, search for a specific article by entering
its PubMed ID in the corresponding box. Once the list of all PubMed publications has been
generated, please follow these steps:
a. Select papers to be included in the application
From the list of all PubMed publications, select the papers published by the
applicant and that the applicant wants to include in the proposal by clicking on the
“Select this publication” button for each article. Pay special attention to potential
homonyms. Do not include abstracts, conference papers, letters to the editor, book
chapters and papers published in journals without IF, unless they are new journals.
It is possible to select all publications that have been retrieved by the system, and
then deselect those that the applicant does not want to include in the application, by
clicking on the “Cancel” button of each unwanted article.
b. Indicate acknowledgement to AIRC and relevance to cancer research
For each publication, please indicate whether it has an acknowledgement to AIRC
and whether it is relevant for cancer research by checking either “YES” or “NO”
(the default is “NO” for both), then click on “OK” to save this information. Please
note: for each selected paper, the system automatically recognizes the position of
the applicant in the list of authors; it is possible to amend this information, if
incorrect, by providing supporting documentation from the main page of the
Publications (see below).
c. Certify accuracy of flags, and save records
Once all selected publications have been flagged, scroll down to the bottom of the
page and check the certification box (“I, the undersigned, certify that all
publications have been carefully checked and correctly flagged for authorship. I am
aware that any mistake or inaccuracy may impact the evaluation of my track
record”) and click on “Add this publication”.
8
[AIRC – fellowships Italy call 2013]
Add Web of Science® publications
From this section it is possible to enter articles that are included in Web of Science® but not
in PubMed (most journals are present in both databases, but there are few exceptions). For
each record, please provide the title, list of authors, year, volume, pages, publication date.
Select the journal from the drop-down menu, which provides all journals listed in Web of
Science®. Mark each paper for authorship, acknowledgement to AIRC, and relevance to
cancer research. Please upload the page of the article where the role of the author in the
published work is certified (not the full article). Finally, check the certification box and click
on “Save” to complete the process.
Add papers in press
Use this section to submit articles already accepted for publication but not yet available
online. For each record, please provide the title, list of authors, year. Select the journal from
the drop-down menu, which lists all Web of Science® indexed journals. Mark each paper for
authorship, acknowledgement to AIRC, and relevance to cancer research. Please upload a
PDF file with the letter of acceptance from the journal. Do not attach the entire manuscript.
Finally, check the certification box and click on “Save” to complete the process.
All publications entered from any of the above sections will be listed in the “Publications” main
page. From here, it is possible to edit the information relative to each paper by clicking on the title
of the publication. Once in the “Update publication” window, please check the appropriate
authorship box and upload the page of the article where the role of the author in the published work
is certified (e.g. for a second or third author who is in fact a co-first author, please upload the PDF
file of the page where it is stated that the PI “equally contributed to this work”). Check “not
assignable” when a publication stems from a consortium in which the relative contribution of each
author is the same. Then check the certification box and click on “Save” to complete the process.
Project keywords
Project keywords will be used by the AIRC Peer Review Office to assign each application to the
most appropriate reviewers. Therefore, a good choice of keywords is extremely important to
ensure that reviewers with the most adequate expertise will evaluate the application. Avoid
keywords that are too generic or too similar with each other; pick a set of keywords that clearly
define the key aspects of your research plan.
Keywords are listed at the end of this Call both in alphabetical order and by topic.
To enter the project keywords (at least one, maximum five) please click on the button
“Enter/Edit Keywords”. In the “Manage Project Keywords” pop-up window, keywords are
grouped by their first letter: for example, by clicking on the letter “C” in the menu it is
possible to visualize all keywords beginning with the letter C, and to select one. To select a
keyword, click on it (the keyword box will turn from grey to blue) and then click on “Save”.
You will be automatically redirected in the main keywords page: click on “Save” at the
bottom of this page to save the record. Repeat this process for each keyword.
Research project
A research project, agreed with the head of the hosting laboratory, must be divided into the
following sections, to be uploaded individually as PDF files:
a. Abstract (max 1 page, approx. 500 words)
b. Background (max 1 page, approx. 500 words)
c. Proposal main body (max 3 pages, approx. 1500 words)
d. Feasibility (max 1 page, approx. 500 words)
e. References (max 1 page, approx. 15 references).
Head of the hosting lab
Please fill in the requested fields, with the personal and institutional data of the head of the hosting
lab.
9
[AIRC – fellowships Italy call 2013]
Letter of acceptance by the head of the hosting lab
A letter of acceptance of the applicant by the head of the hosting lab (max 2 pages, approx. 1000
words) must be uploaded as PDF file of the signed, scanned original. In this document, the
prospective supervisors must indicate what grant/funding will be used to support the research
project described in the application; in addition, they should briefly describe their mentoring
activities (e.g. frequency of meetings with fellows, number of PhD students or post doc fellows
trained, etc). The letter should also state if the hosting institution will offer adequate training
resources.
Research and professional experience of the head of the hosting lab
Click on “Add new record” and list, in reverse chronological order, the most important positions
held by the head of the hosting lab. For each entry, please indicate the Institution, City, Country,
time frame and the position held.
Publications of the head of the hosting lab
Please enter all cancer-related publications published by the head of the hosting lab in the past five
years (2008-2013). Click on “Add publications” and follow the online procedure described in “Add
PubMed publications” of the section “Publications”, above.
Head of the laboratory of origin
Please fill in the requested fields, with the personal and institutional data of the head of the
laboratory of origin. If there is no mobility, please click on “Same as the Head of the hosting lab”.
Letter of presentation by the head of the laboratory of origin (only in case of mobility)
A letter by the head of the laboratory of origin, presenting the applicant, must be uploaded as PDF
file of the signed, scanned original.
Bio-Ethical Requirements
Check boxes as applicable for human and animal experimentation.
Research on humans
Please note that human experimentation is not limited to clinical studies with healthy volunteers
and/or patients. It includes use of human biological samples (commercially available human cell
lines e.g. from ATCC are exempt), human genetic material and human data collection (e.g. genetic
information, health, etc.).
For clinical trials involving human subjects, and for studies with human biological samples, the
approval of the local Ethics Committee/Institutional Review Board (IRB) together with a copy of
the informed consent (if requested by the Ethics Committee) is mandatory. If available at the time of
submission, the documentation must be included in the application as PDF file by clicking on
“Select” under the “Clearance from Ethic Committee” header.
The approval document issued by the Ethics Committee MUST indicate:
- the date when the IRB meeting was held: approvals obtained more than 3 years ago (i.e.
prior to 2010) are NOT acceptable;
- the name of the applicant and/or the name of the head of the hosting lab;
- a clear reference to the studies described in the proposal (e.g. the title of the application).
In case biospecimens have been obtained by external sources/collaborators, the clearance documents
must be provided by the collaborator’s research center.
In any case, if the research deals with human biological samples, genetic materials or data
collection, the research proposal should include information about:
10
[AIRC – fellowships Italy call 2013]
-
how the samples, materials or data are collected;
whether the samples, materials or data are collected specifically for the proposed research
project;
how the samples, materials or data are dismissed.
If the approval from the Ethics Committee is not available by the submission deadline, the PI must
obtain it by November 15th 2013 and either upload it as PDF file in the “Personal Area” or send it
to the AIRC Peer Review Office by e-mail ([email protected]) and in paper (Via San
Vito 7, 20123 Milano).
Research on animals
Animal experimentation must conform to all regulations protecting animals used for research
purposes according to current international and national rules.
If the research plan involves animal experimentation, the applicant must select one of the available
options in the online form:
• I have obtained the clearance from the competent animal research ethics committee to carry out
the described animal experimentation, and I am attaching it to the application;
• I have not obtained the clearance from the competent animal research ethics committee yet, but I
have requested it and will send it to the AIRC Peer Review Office by November 15th 2013;
• there is not active Ethical Committee for animal research at my Institute, but the procedures
related to animal use have been communicated to the Italian Ministry of Health and a copy of this
communication is attached to the current application;
• there is not an active animal research ethics committee in my Institute; I have yet to communicate
the procedures related to animal use to the Italian Ministry of Health but I will do so and I will send
a copy of this communication to the AIRC Peer Review Office by November 15th 2013.
In any case, by signing the Bio-Ethical requirements page the applicant declares that the research
studies are accurately described in the proposal and conform to all regulations protecting animals
used for research purposes, including those of the DL 116/92. The experiments described in the
proposal will be performed following the guidelines described in: Workman P. et al.: “Guidelines
for the welfare and use of animals in cancer research”. Br. J. Cancer (2010) 102: 1555-1577.
The required documentation for animal experimentation, if not available by the submission
deadline, must be sent to AIRC by e-mail ([email protected]) or directly uploaded in
the PI’s Personal Area by November 15th 2013. No paper copy of this documentation is required.
Please note: Ethics Committee(s) approval(s) for human and/or animal research are not necessary
for the assessment of the scientific merit of an application, during the review; however, if the
application is approved, funds will be granted only if the required Ethical Committee certifications
have been sent to AIRC. AIRC is not responsible for any inaccuracy in the ethical documentation
provided and does not accept any liability for harm to participants in AIRC funded trials.
Submission
To submit the application, go to “Summary” (on the lower left of the main page). All sections must
be completed and must have the green “OK” label. Please make sure that all data are correctly
reported in the PDF Draft prior to submitting the application. Click on “Submit” to finalize the
submission.
11
[AIRC – fellowships Italy call 2013]
Deadlines
DEADLINES ARE STRICTLY ENFORCED: applications submitted after the deadline will
not be accepted.
Deadlines for applications (by 23:59, Central European Time, of the indicated dates):
New applications
online form release date
April 29, 2013
electronic submission deadline
June 24, 2013
paper submission (postmark) deadline (*)
June 26, 2013
notification of results
November 30, 2013
start of fellowship
January 1, 2014
(*) Only the following pages are required in paper format and must be mailed by the indicated
deadline:
•
•
•
•
Title Page, signed by the applicant and Legal representative of the hosting institution
Abstract
Bioethical requirements page, signed by the PI
Only if research in humans is planned: Clearance from the Ethics Committee.
Send all paper documentation to the following address:
AIRC
Direzione Scientifica
via San Vito 7
20123 Milano
*** Paper documentation marked with “draft” is not valid. Please print the requested pages
only after completion of the online submission ***
If these documents are not sent by the indicated deadline, applications will not be sent out for
review. Make sure to keep a receipt with the mailing date.
12
[AIRC – fellowships Italy call 2013]
Deadlines for renewals and final report (by 23:59, Central European Time, of the indicated
dates):
Annual fellowships
Final report
online form release date
November 10, 2014
electronic submission deadline
December 10, 2014
online form release date
April 14, 2014
electronic submission deadline
June 3, 2014
online form release date
November 10, 2015
electronic submission deadline
December 14, 2015
online form release date
April 14, 2014
electronic submission deadline
June 3, 2014
online form release date
April 14, 2015
electronic submission deadline
June 3, 2015
online form release date
November 10, 2016
electronic submission deadline
December 14, 2016
Biennial fellowships
Renewal for 2nd year of funding
Final report
Triennial fellowships
Renewal for 2nd year of funding
Renewal for 3rd year of funding
Final report
The deadlines for renewal requests and final reports may be subjected to changes. In this
case, fellows will be notified of the new deadlines by e-mail.
13
KEYWORDS IN ALPHABETICAL ORDER
Adenovirus
Caveolin
Adhesion dynamics
CD133/Stem cell markers
Adjuvant therapy
Cell adhesion and/or cell adhesion molecules
Aging
Cell cycle
AIDS/HIV/Kaposi
Cell cycle checkpoint G1/S
ALL
Cell cycle checkpoint G2/M
AML
Cell differentiation and/or differentiation therapy
Androgen and/or receptors
Cell migration, motility and/or invasion
Aneuploidy
Cell polarity
Angiogenesis and/or vasculogenesis
Cell signaling
Animal models
Centrosome
Anti-angiogenic therapy
Cervix or endometrial ca.
Antibody/mAb therapy
Chemistry
Apoptosis
Chemokines
Aromatase and/or inhibitors
Chemotherapy and/or chemotherapic drugs
ATM pathway
Chromatin remodeling
ATR pathway
Circulating tumor cells
Autoimmunity/Autoantibodies
Clinical practice guidelines
Autophagy
Clinical trials
B cells
CLL
bcl2 family
CML
BCR-Abl/Abl
Colorectal and/or Intestinal ca.
Beta-catenin/Wnt pathway
Combination therapy
Biochemistry
Comparative genomics hybridization (CGH)
Bioinformatics
Computational biology
Biomarkers
Computer Tomography (CT Scan)
Biomolecular modelling
Costimulatory molecules
Biophysics
COX2
Bladder tumor
Crosstalk
Body mass index (BMI) and/or obesity
Crystallography
Bone disease
CTL
Bone morphogenetic protein (BMP)
Cyclic AMP
BRAF/RAF kinases
Cyclins and/or inhibitors
Brain and/or nervous system tumors
Cytogenetics and/or chromosome alterations
BRCA
Cytokines/Interleukins
Breast ca.
Cytoskeleton
Burkitt lymphoma
Dendritic cells
C.elegans
Diagnosis
Cachexia
Diet
Cadherins
DNA damage
Cancer stem cells
DNA double strand break repair (DSBR)
Carcinogenesis
DNA methylation
Caspases
DNA recombination
KEYWORDS IN ALPHABETICAL ORDER
DNA repair
Glioma and/or glioblastoma
DNA replication
Glucocorticoids and/or receptors
DNA single strand break repair (SSBR)
Glucose metabolism and/or Warburg effect
Docking
Glycoproteins and/or glycosylation
Drosophila
Golgi
Drug delivery
G-proteins and/or GPCR
Drug discovery and/or development
Granulocytes
Drug response and/or resistance
Growth factors and/or receptors
Drug screening
Growth induction and/or growth arrest
Drug toxicity
GVDH and/or Graft versus Tumor
EGF and/or receptors
Gynecological tumors
Embryonic development
Head and neck ca.
Endocrinology
Heat shock proteins (HSP)
Endocytosis
Hedgehog pathway
Endoplasmic reticulum (ER)
Hematologic malignancies
Endothelial cells
Hematopoiesis
Epidemiology
Hematopoietic stem cells
Epigenetics
Hepatitis B virus (HBV)
Epithelial mesenchyme transition (EMT)
Hepatitis C virus (HCV)
Epstein-Barr Virus (EBV)
Hepatocellular carcinoma (HCC)
Estrogens and/or receptors
HER1-2-3-4
Extracellular Matrix (ECM)/Stroma
Hereditary DNA repair disorders
Fas and/or FasL
Hereditary tumors
FGF and/or receptor
Herpes virus
Flow cytometry
High Mobility Group Proteins (HMG)
Fluorescence in situ hybridization (FISH)
Hippo pathway
Fluorescence resonance energy transfer (FRET)
Histone modifications
Focal Adhesion/FAK
HLA/Major Histocompatibility Complex (MHC)
Folate and/or receptor
Hodgkin's lymphoma
Functional genomics
Homologous recombination
Functional validation of target genes
Hormones
Fusion genes
Human Papilloma Virus (HPV)
Gastric ca.
Hypoxia/Hypoxia-inducibile Factors (HIF-1)
Gene alteration/gain or loss
Immune escape
Gene expression and/or profile
Immunization
Gene regulation
Immuno-editing
Gene therapy
Immunohistochemistry
Genetics
Immunosuppression and/or suppressor cells
Genome wide screening/GWAS
Immunotherapy
Genomic imprinting
In vitro imaging and/or live cell imaging
Genomic/Genetic instability
In vivo imaging
Genomics
Infection
Genotoxicity
Inflammation and/or inflammatory cytokines
KEYWORDS IN ALPHABETICAL ORDER
Inhibitor of apoptosis proteins (IAPs)
mRNA translation
Innate immunity
Multidrug resistance (MDR)
Insulin
Mutation (somatic and/or germline)
Insulin-like growth factor (IGF) and/or receptors
Myc
Integrins and/or Integrin-linked kinase (ILK)
Myeloma
Interferons
Nanotechnology/Nanoparticles
Ion channels
Netrin receptors
Jak/Stat pathway
Neuroblastoma
Kidney ca.
Next generation sequencing
Kinase/Kinome
NF-kB family
Lentivirus
Nitric oxide
Leukaemia
NK and/or NKT cells
Lipid metabolism
NMR spectroscopy
Liver development and/or regeneration
Non apoptotic cell death
Loss of heterozygosity (LOH)
Non melanoma skin tumors
Lung ca.
Normal stem cells
Lymphatics and/or lymphangiogenesis
Notch pathway
Lymphocyte differentation
Nuclear medicine
Lymphomas
Nuclear receptor
Macrophages and/or monocytes
Nuclear structures
Magnetic resonance imaging (MRI)
Oncogenes
MAP Kinases
Oncogenic virus/Viral oncology
Mass spectrometry
Organic compounds
Mathematical modeling
Osteopontin
Matrix metalloproteases (MMP) and/or inhibitors
Osteosarcoma
MDM2
Ovarian ca.
Medulloblastoma
Oxidative stress and/or Reactive Oxygen Species (ROS)
Melanoma
p21 - activated kinases (PAK)
Membrane biology
p53, p63, p73
Mesothelioma
Palliative care
MET/HGF
Pancreas ca.
Metabolism/Metabolomics
PDGF and/or receptors
Metastasis
Pediatric tumors
Microarrays
Peptides as drugs
Microenvironment
PET and/or PET-CT
microRNA
Phage display
Microscopy
Phagocytes and/or phagocytosis
Minimal Residual Disease (MRD)
Pharmacogenetics/Pharmacogenomics
Mitochondria
Pharmacokinetics
Mitosis
Pharmacology
Monoclonal antibodies (mAbs) and/or immunoconjugates
Phosphatases
Mouse models
Phospholipids
mRNA processing
Phosphorylation
KEYWORDS IN ALPHABETICAL ORDER
PI3K/Akt/PTEN/mTOR pathway
Surgery
Poly-ADP-ribose polymerase (PARP)
Survival analysis
Polymorphisms/SNPs
Synthetic lethality
Post-translational modification
Systems biology
Precancerous lesions
T cells/TCR
Preclinical studies
T helpers
Prevention and/or chemoprevention
Target therapy
Prognosis
Telomere and/or telomerase
Prostaglandins
Testis ca.
Prostate ca.
TGF and/or receptors
Proteasome
Thymoma
Protein microarrays
Thyroid ca.
Proteomics
Thyroid hormone
Radionuclide therapy
Tissue microarrays (TMA)
Radiosensitivity and/or resistance
TNF and/or receptors
Radiotherapy
Tolerance
Radiotoxicity
Toll-like receptors (TLR)
RAS/RAS inhibitors
Topoisomerase
Rb/Rb family
TRAIL
Response and/or resistance to therapy
Transcription
RET
Transcription factors
Retinoic acid and/or receptors
Transformation assays
Retrospective studies
Transgenic mice
Rho GTPases family
Translesion synthesis
Risk factors
Translocation
RNA binding proteins
Transplantation
RNA splicing
Treg cells
Sarcoma
Triple negative breast ca.
Screening
Tumor antigen
Senescence
Tumor dormancy
Signal transduction inhibitors
Tumor suppressor genes
siRNA and/or non coding RNA
Tumor-stroma interaction
Small molecule inhibitors
Tyrosine kinase receptors (TKR) and/or inhibitors
Smoking
Ubiquitin and/or ubiquitination
Soft tissue tumors
Urokinase-Plasminogen System (uPA, uPAR, PAI)
Solid tumors
Vaccine
SPECT
VEGF and/or receptor
Spheroids/3D cultures
Virology
Src family
Von Hippel-Lindau (VHL)
Staging
Wilms' Tumor Gene (WT1)
Statistics
Xenopus
Stress response
Yeast
SUMO and/or sumoylation
Zebrafish
KEYWORDS BY TOPIC
Adhesion and stroma
Angiogenesis
Adhesion dynamics
Angiogenesis and/or vasculogenesis
Cadherins
Endothelial cells
Caveolin
Hypoxia/Hypoxia-inducibile Factors (HIF-1)
Cell adhesion and/or cell adhesion molecules
Lymphatics and/or lymphangiogenesis
Cell migration, motility and/or invasion
VEGF and/or receptor
Cell polarity
Von Hippel-Lindau (VHL)
Cytoskeleton
Extracellular Matrix (ECM)/Stroma
Focal Adhesion/FAK
Integrins and/or Integrin-linked kinase (ILK)
Matrix metalloproteases (MMP) and/or inhibitors
Microenvironment
Osteopontin
Tumor-stroma interaction
Urokinase-Plasminogen System (uPA, uPAR, PAI)
KEYWORDS BY TOPIC
Cell death and apoptosis
Clinical topics
Apoptosis
Cachexia
Autophagy
Computer Tomography (CT Scan)
bcl2 family
Diagnosis
Caspases
Drug toxicity
Fas and/or FasL
Endocrinology
Inhibitor of apoptosis proteins (IAPs)
GVHD and/or Graft versus Tumor
Mitochondria
Magnetic resonance imaging (MRI)
Non apoptotic cell death
Metastasis
p53, p63, p73
Minimal Residual Disease (MRD)
Senescence
Nuclear medicine
TRAIL
Palliative care
PET and/or PET-CT
Prognosis
Retrospective studies
SPECT
Staging
Survival analysis
Transplantation
KEYWORDS BY TOPIC
Genes, proteins and miscellanea
ATM pathway
Poly-ADP-ribose polymerase (PARP)
ATR pathway
Proteasome
BCR-Abl/Abl
RNA binding proteins
Bone morphogenetic protein (BMP)
Stress response
BRAF/RAF kinases
SUMO and/or sumoylation
BRCA
Telomere and/or telomerase
Embryonic development
Topoisomerase
Endocytosis
Ubiquitin and/or ubiquitination
Endoplasmic reticulum (ER)
Wilms' Tumor Gene (WT1)
Epigenetics
Epithelial mesenchyme transition (EMT)
FGF and/or receptor
Glucocorticoids and/or receptors
Glucose metabolism and/or Warburg effect
Glycoproteins and/or glycosylation
Golgi
Heat shock proteins (HSP)
High Mobility Group Proteins (HMG)
Ion channels
Lipid metabolism
Liver development and/or regeneration
MDM2
Membrane biology
Myc
Netrin receptors
Nitric oxide
Oncogenes
p21 - activated kinases (PAK)
Phosphatases
Phospholipids
KEYWORDS BY TOPIC
Genetics
Aneuploidy
Pharmacogenetics/Pharmacogenomics
Centrosome
Polymorphisms/SNPs
Chromatin remodeling
Post-translational modification
Cytogenetics and/or chromosome alterations
RNA splicing
DNA damage
siRNA and/or non coding RNA
DNA double strand break repair (DSBR)
Synthetic lethality
DNA methylation
Transcription
DNA recombination
Transcription factors
DNA repair
Transformation assays
DNA replication
Translesion synthesis
DNA single strand break repair (SSBR)
Translocation
Functional genomics
Tumor suppressor genes
Fusion genes
Gene alteration/gain or loss
Gene expression and/or profile
Gene regulation
Genetics
Genome wide screening/GWAS
Genomic imprinting
Genomic/Genetic instability
Genomics
Hereditary DNA repair disorders
Histone modifications
Homologous recombination
Loss of heterozygosity (LOH)
microRNA
Mitosis
mRNA processing
mRNA translation
Mutation (somatic and/or germline)
Nuclear structures
KEYWORDS BY TOPIC
Immunology
Autoimmunity/Autoantibodies
Tolerance
B cells
Toll-like receptors (TLR)
Chemokines
Treg cells
Costimulatory molecules
Tumor antigen
COX2
Tumor dormancy
CTL
Vaccine
Cytokines/Interleukins
Dendritic cells
Granulocytes
Hematopoiesis
HLA/Major Histocompatibility Complex (MHC)
Immune escape
Immunization
Immuno-editing
Immunosuppression and/or suppressor cells
Immunotherapy
Infection
Inflammation and/or inflammatory cytokines
Innate immunity
Interferons
Lymphocyte differentation
Macrophages and/or monocytes
Monoclonal antibodies (mAbs) and/or immunoconjugates
NF-kB family
NK and/or NKT cells
Phagocytes and/or phagocytosis
Prostaglandins
T cells/TCR
T helpers
TNF and/or receptors
KEYWORDS BY TOPIC
Methods
Animal models
Proteomics
Biochemistry
Spheroids/3D cultures
Bioinformatics
Statistics
Biomolecular modelling
Systems biology
Biophysics
Tissue microarrays (TMA)
C.elegans
Transgenic mice
Chemistry
Xenopus
Comparative genomics hybridization (CGH)
Yeast
Computational biology
Zebrafish
Crystallography
Docking
Drosophila
Risk factors
Epidemiology
Aging
Flow cytometry
Biomarkers
Fluorescence in situ hybridization (FISH)
Body mass index (BMI) and/or obesity
Fluorescence resonance energy transfer (FRET)
Carcinogenesis
Functional validation of target genes
Diet
Immunohistochemistry
Genotoxicity
In vitro imaging and/or live cell imaging
Metabolism/Metabolomics
In vivo imaging
Organic compounds
Mass spectrometry
Oxidative stress and/or Reactive Oxygen Species (ROS)
Mathematical modeling
Precancerous lesions
Microarrays
Prevention and/or chemoprevention
Microscopy
Risk factors
Mouse models
Screening
Nanotechnology/Nanoparticles
Smoking
Next generation sequencing
NMR spectroscopy
Phage display
Protein microarrays
KEYWORDS BY TOPIC
Signaling and cell cycle
Androgen and/or receptors
Rb/Rb family
Beta-catenin/Wnt pathway
RET
Cell cycle
Retinoic acid and/or receptors
Cell cycle checkpoint G1/S
Rho GTPases family
Cell cycle checkpoint G2/M
Src family
Cell differentiation and/or differentiation therapy
TGF and/or receptors
Cell signaling
Thyroid hormone
Crosstalk
Tyrosine kinase receptors (TKR) and/or inhibitors
Cyclic AMP
Cyclins and/or inhibitors
EGF and/or receptors
Stem cells
Estrogens and/or receptors
Cancer stem cells
Folate and/or receptor
CD133/Stem cell markers
G-proteins and/or GPCR
Circulating tumor cells
Growth factors and/or receptors
Hematopoietic stem cells
Growth induction and/or growth arrest
Normal stem cells
Hedgehog pathway
HER1-2-3-4
Hippo pathway
Hormones
Insulin
Insulin-like growth factor (IGF) and/or receptors
Jak/Stat pathway
Kinase/Kinome
MAP Kinases
MET/HGF
Notch pathway
Nuclear receptor
PDGF and/or receptors
Phosphorylation
PI3K/Akt/PTEN/mTOR pathway
RAS/RAS inhibitors
KEYWORDS BY TOPIC
Types of tumors
ALL
Solid tumors
AML
Testis ca.
Bladder tumor
Thymoma
Bone disease
Thyroid ca.
Brain and/or nervous system tumors
Triple negative breast ca.
Breast ca.
Burkitt lymphoma
Cervix or endometrial ca.
Therapies
CLL
Adjuvant therapy
CML
Anti-angiogenic therapy
Colorectal and/or Intestinal ca.
Antibody/mAb therapy
Gastric ca.
Aromatase and/or inhibitors
Glioma and/or glioblastoma
Chemotherapy and/or chemotherapic drugs
Gynecological tumors
Clinical practice guidelines
Head and neck ca.
Clinical trials
Hematologic malignancies
Combination therapy
Hepatocellular carcinoma (HCC)
Drug delivery
Hereditary tumors
Drug discovery and/or development
Hodgkin's lymphoma
Drug response and/or resistance
Kidney ca.
Drug screening
Leukaemia
Gene therapy
Lung ca.
Multidrug resistance (MDR)
Lymphomas
Peptides as drugs
Medulloblastoma
Pharmacokinetics
Melanoma
Pharmacology
Mesothelioma
Preclinical studies
Myeloma
Radionuclide therapy
Neuroblastoma
Radiosensitivity and/or resistance
Non melanoma skin tumors
Radiotherapy
Osteosarcoma
Radiotoxicity
Ovarian ca.
Response and/or resistance to therapy
Pancreas ca.
Signal transduction inhibitors
Pediatric tumors
Small molecule inhibitors
Prostate ca.
Surgery
Sarcoma
Target therapy
Soft tissue tumors
KEYWORDS BY TOPIC
Viruses
Adenovirus
AIDS/HIV/Kaposi
Epstein-Barr Virus (EBV)
Hepatitis B virus (HBV)
Hepatitis C virus (HCV)
Herpes virus
Human Papilloma Virus (HPV)
Lentivirus
Oncogenic virus/Viral oncology
Virology